New pharmacological options in the treatment of Alzheimer's disease

被引：2
|
作者：
Kleinova, L. [1 ,2 ]
Cerman, J. [2 ]
Hlavka, J. [3 ]
Hort, J. [2 ]
机构：
[1] 1 LF UK, Vseobecne Lekarstvi, Prague, Czech Republic
[2] Neurol Klin 2 LF UK, Kognitivni Ctr, V Uvalu 84, Prague 15006, Czech Republic
[3] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA
来源：
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE | 2022年 / 85卷 / 06期
关键词：
Alzheimer?s disease; phase three testing  of new drugs; β -amyloid; tau protein; neuroinflammatory theory; ric symptoms; neuroprotection; BETA; TRAMIPROSATE; INHIBITION; GUANFACINE; DEMENTIA; TRIAL;
D O I：
10.48095/cccsnn2022462
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
A new era of innovative treatment options for Alzheimer's disease is emerging. New goals of treatment are being developed with various monoclonal antibodies targeting potentially pathological molecules involved in the pathogenesis of Alzheimer's disease. The aim of this review is to acquaint the reader with new potential drugs, while most of those mentioned in this review are in the third phase of clinical trials.
引用
收藏
页码：462 / 469
页数：8
相关论文
共 50 条
  • [1] Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer's disease
    Javed, Binish
    Javed, Amaan
    Kow, Chia Siang
    Hasan, Syed Shahzad
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, : 501 - 514
  • [2] Updates on pharmacological treatment for Alzheimer's disease
    Tipton, Philip W.
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2024, 58 (02) : 150 - 160
  • [3] Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome
    Caraci, Filippo
    Iulita, M. Florencia
    Pentz, Rowan
    Aguilar, Lisi Flores
    Orciani, Chiara
    Barone, Concetta
    Romano, Corrado
    Drago, Filippo
    Cuello, A. Claudio
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 817 : 7 - 19
  • [4] New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs
    Salomone, Salvatore
    Caraci, Filippo
    Leggio, Gian Marco
    Fedotova, Julia
    Drago, Filippo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (04) : 504 - 517
  • [5] Treatment options for Alzheimer's disease
    Seux, M. -L.
    de Rotrou, J.
    Rigaud, A. -S.
    PSN-PSYCHIATRIE SCIENCES HUMAINES NEUROSCIENCES, 2008, 6 (02): : 82 - 90
  • [6] Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options
    Cummings, Jeffrey L.
    Tong, Gary
    Ballard, Clive
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 67 (03) : 779 - 794
  • [7] Pharmacological Treatment of Alzheimer Disease
    Massoud, Fadi
    Leger, Gabriel C.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2011, 56 (10): : 579 - 588
  • [8] Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia
    Szeto, Jennifer Y. Y.
    Lewis, Simon J. G.
    CURRENT NEUROPHARMACOLOGY, 2016, 14 (04) : 326 - 338
  • [9] Evidence of Clinical Efficacy and Pharmacological Mechanisms of Resveratrol in the Treatment of Alzheimer's Disease
    Jin, Sian
    Guan, Xuefeng
    Min, Dongyu
    CURRENT ALZHEIMER RESEARCH, 2023, 20 (08) : 588 - 602
  • [10] Current treatment options for people with Alzheimer's disease in Croatia
    Mimica, Ninoslav
    Presecki, Paola
    CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 187 (1-3) : 409 - 410
12345